Literature DB >> 21856745

miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

Eri Nishikawa1, Hirotaka Osada, Yasumasa Okazaki, Chinatsu Arima, Shuta Tomida, Yoshio Tatematsu, Ayumu Taguchi, Yukako Shimada, Kiyoshi Yanagisawa, Yasushi Yatabe, Shinya Toyokuni, Yoshitaka Sekido, Takashi Takahashi.   

Abstract

Lung cancers with neuroendocrine (NE) features are often very aggressive but the underlying molecular mechanisms remain elusive. The transcription factor ASH1/ASCL1 is a master regulator of pulmonary NE cell development that is involved in the pathogenesis of lung cancers with NE features (NE-lung cancers). Here we report the definition of the microRNA miR-375 as a key downstream effector of ASH1 function in NE-lung cancer cells. miR-375 was markedly induced by ASH1 in lung cancer cells where it was sufficient to induce NE differentiation. miR-375 upregulation was a prerequisite for ASH1-mediated induction of NE features. The transcriptional coactivator YAP1 was determined to be a direct target of miR-375. YAP1 showed a negative correlation with miR-375 in a panel of lung cancer cell lines and growth inhibitory activities in NE-lung cancer cells. Our results elucidate an ASH1 effector axis in NE-lung cancers that is functionally pivotal in controlling NE features and the alleviation from YAP1-mediated growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856745     DOI: 10.1158/0008-5472.CAN-11-1020

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.

Authors:  L A Selth; R Das; S L Townley; I Coutinho; A R Hanson; M M Centenera; N Stylianou; K Sweeney; C Soekmadji; L Jovanovic; C C Nelson; A Zoubeidi; L M Butler; G J Goodall; B G Hollier; P A Gregory; W D Tilley
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

2.  MicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAP.

Authors:  Fei Xu; Abu Shufian Ishtiaq Ahmed; Xiuhua Kang; Guoqing Hu; Fang Liu; Wei Zhang; Jiliang Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-20       Impact factor: 8.311

3.  MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer.

Authors:  Roland Hubaux; Daiana D Becker-Santos; Katey S S Enfield; Stephen Lam; Wan L Lam; Victor D Martinez
Journal:  Metabolomics (Los Angel)       Date:  2012-03-21

4.  Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.

Authors:  Kaiji Fan; Cathrin Ritter; Paul Nghiem; Astrid Blom; Monique E Verhaegen; Andrzej Dlugosz; Niels Ødum; Anders Woetmann; Richard W Tothill; Rodney J Hicks; Michael Sand; David Schrama; Dirk Schadendorf; Selma Ugurel; Jürgen C Becker
Journal:  Clin Cancer Res       Date:  2018-07-30       Impact factor: 12.531

Review 5.  Structures of YAP protein domains reveal promising targets for development of new cancer drugs.

Authors:  Marius Sudol; Denis C Shields; Amjad Farooq
Journal:  Semin Cell Dev Biol       Date:  2012-05-17       Impact factor: 7.727

6.  Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

Authors:  Antonio García Escudero; Enrique Rodríguez Zarco; Juan Carlos Girón Arjona; María José Ríos Moreno; Katherine Gallardo Rodríguez; Ana Vallejo Benítez; Ricardo González Cámpora
Journal:  Virchows Arch       Date:  2016-06-14       Impact factor: 4.064

7.  Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation.

Authors:  Hailong Zhang; Tao Liu; Sha Yi; Lubing Gu; Muxiang Zhou
Journal:  Mol Oncol       Date:  2015-03-24       Impact factor: 6.603

8.  MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical-pathological features and outcome.

Authors:  Francesca Galuppini; Loris Bertazza; Susi Barollo; Elisabetta Cavedon; Massimo Rugge; Vincenza Guzzardo; Diana Sacchi; Sara Watutantrige-Fernando; Federica Vianello; Caterina Mian; Gianmaria Pennelli
Journal:  Virchows Arch       Date:  2017-08-31       Impact factor: 4.064

9.  Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Authors:  Matthias Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  Thyroid       Date:  2013-09-19       Impact factor: 6.568

10.  Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma.

Authors:  Jena Hudson; Eric Duncavage; Anna Tamburrino; Paolo Salerno; Liqiang Xi; Mark Raffeld; Jeffrey Moley; Rebecca D Chernock
Journal:  Exp Mol Pathol       Date:  2013-05-16       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.